Received Dec 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | — |
patients have accidentally received a third dose in the past; This non-serious case was reported by a other health professional via sales rep and described the occurrence of extra dose administered in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on an unknown date) and Shingrix (2nd dose received on an unknown date). On an unknown date, the patients received the 3rd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patients experienced extra dose administered (Verbatim: patients have accidentally received a third dose in the past). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 25-NOV-2025 No other products had been received by the patients. The state vaccine registry had not been a reliable source to verify past vaccination. The pharmacy felt that they might have given a third dose of Shingrix accidentally because of the inability to verify previous doses. The batch number was not provided, and unable to contact the reporter.